GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $15,000 | +114.3% | 214 | 0.0% | 0.00% | – |
Q2 2022 | $7,000 | 0.0% | 214 | 0.0% | 0.00% | – |
Q1 2022 | $7,000 | +16.7% | 214 | 0.0% | 0.00% | – |
Q4 2021 | $6,000 | +20.0% | 214 | 0.0% | 0.00% | – |
Q3 2021 | $5,000 | +25.0% | 214 | +84.5% | 0.00% | – |
Q2 2021 | $4,000 | -20.0% | 116 | 0.0% | 0.00% | – |
Q1 2021 | $5,000 | 0.0% | 116 | 0.0% | 0.00% | – |
Q4 2020 | $5,000 | -73.7% | 116 | -66.7% | 0.00% | – |
Q3 2020 | $19,000 | +11.8% | 348 | +2.4% | 0.00% | – |
Q2 2020 | $17,000 | 0.0% | 340 | 0.0% | 0.00% | – |
Q1 2020 | $17,000 | -37.0% | 340 | 0.0% | 0.00% | – |
Q4 2019 | $27,000 | +42.1% | 340 | -11.0% | 0.00% | – |
Q3 2019 | $19,000 | 0.0% | 382 | +6.7% | 0.00% | – |
Q2 2019 | $19,000 | 0.0% | 358 | 0.0% | 0.00% | – |
Q1 2019 | $19,000 | +90.0% | 358 | +48.5% | 0.00% | – |
Q4 2018 | $10,000 | +11.1% | 241 | 0.0% | 0.00% | – |
Q3 2018 | $9,000 | -18.2% | 241 | 0.0% | 0.00% | – |
Q2 2018 | $11,000 | -8.3% | 241 | 0.0% | 0.00% | – |
Q1 2018 | $12,000 | – | 241 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
Grace Capital | 131,549 | $5,697,000 | 3.60% |
Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |